Vestibular Rehabilitation Therapy (VRT)
Treatment for Meniere's Disease
Typical Dosage: 30-60 min sessions, 1-3 times/week
Effectiveness
65%
Safety Score
95%
Clinical Trials
1
Participants
6K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
30-60 min sessions, 1-3 times/week
Time to Effect
4-12 weeks
Treatment Duration
6-12 weeks initial course, then home exercises
Evidence Quality
MODERATEConfidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$150
Side Effect Mgmt:$0
Total Annual:$750
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$1,000
Prescription Access Economics
Annual Societal Loss per Patient
$140
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$40/year
Travel + wait time
Insurance Admin Cost
$100/year
Prior auth, claims
Rx Price
$750/year
Potential OTC Price
$400/year
Estimated if OTC available
Early Treatment Benefit
+0.10 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWVestibular Rehabilitation Therapy (VRT) Outcomes
for Meniere's Disease
Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+75%
Common Side Effects
Temporary increase in dizziness
+10%
Fatigue
+5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov